Literature DB >> 11310820

Multiple sclerosis: current pathophysiological concepts.

D M Wingerchuk1, C F Lucchinetti, J H Noseworthy.   

Abstract

Multiple sclerosis (MS) is an often disabling disease primarily affecting young adults that exhibits extraordinary clinical, radiological, and pathological heterogeneity. We review the following: (a) known environmental and genetic factors that contribute to MS susceptibility; (b) current knowledge regarding fundamental pathophysiological processes in MS, including immune cell recruitment and entry into the central nervous system (CNS), formation of the plaque, and orchestration of the immune response; (c) descriptive and qualitative distinct pathological patterns in MS and their implications; (d) the evidence supporting the causative role of direct toxins, cell-mediated and humorally mediated immune mechanisms, and the concept of a "primary oligodendrogliopathy" in demyelination and axonal injury; (e) the potential benefits of inflammation; (f) the prospects for remyelination; and (g) therapeutic implications and approaches suggested by putative pathophysiological mechanisms.

Entities:  

Mesh:

Year:  2001        PMID: 11310820     DOI: 10.1038/labinvest.3780235

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  44 in total

Review 1.  Chemokines and glial cells: a complex network in the central nervous system.

Authors:  Elena Ambrosini; Francesca Aloisi
Journal:  Neurochem Res       Date:  2004-05       Impact factor: 3.996

Review 2.  Autoantibodies with enzymatic properties in human autoimmune diseases.

Authors:  Bharath Wootla; Sébastien Lacroix-Desmazes; Arthur E Warrington; Allan J Bieber; Srini V Kaveri; Moses Rodriguez
Journal:  J Autoimmun       Date:  2011-05-31       Impact factor: 7.094

3.  A small-molecule inhibitor of macrophage migration inhibitory factor for the treatment of inflammatory disease.

Authors:  Aaron P Kithcart; Gina M Cox; Thais Sielecki; Abigail Short; James Pruitt; Tracey Papenfuss; Todd Shawler; Ingrid Gienapp; Abhay R Satoskar; Caroline C Whitacre
Journal:  FASEB J       Date:  2010-07-12       Impact factor: 5.191

4.  Targeting macrophages by an aza-anthrapyrazole to ameliorate experimental autoimmune encephalomyelitis.

Authors:  Boren Lin; Dylan Launder; Destiny Y Bailey; Frank K Assifuah; Olivia A Miller; Heather R Conti; Jianyang Du; Boyd M Koffman
Journal:  Mult Scler Relat Disord       Date:  2020-05-16       Impact factor: 4.339

5.  The impact of pain and other symptoms on quality of life in women with relapsing-remitting multiple sclerosis.

Authors:  Pamela K Newland; Robert T Naismith; Margaret Ullione
Journal:  J Neurosci Nurs       Date:  2009-12       Impact factor: 1.230

6.  MicroRNA expression profiling of oligodendrocyte differentiation from human embryonic stem cells.

Authors:  Brian S Letzen; Cyndi Liu; Nitish V Thakor; John D Gearhart; Angelo H All; Candace L Kerr
Journal:  PLoS One       Date:  2010-05-05       Impact factor: 3.240

7.  Peripheral third cranial nerve enhancement in multiple sclerosis.

Authors:  M Tariq Bhatti; Ilona M Schmalfuss; Lorna S Williams; Ronald G Quisling
Journal:  AJNR Am J Neuroradiol       Date:  2003-08       Impact factor: 3.825

8.  Nanopore Fabrication and Application as Biosensors in Neurodegenerative Diseases.

Authors:  Brian Lenhart; Xiaojun Wei; Zehui Zhang; Xiaoqin Wang; Qian Wang; Chang Liu
Journal:  Crit Rev Biomed Eng       Date:  2020

Review 9.  Developing therapeutics for the treatment of multiple sclerosis.

Authors:  David J Virley
Journal:  NeuroRx       Date:  2005-10

10.  von-Willebrand factor influences blood brain barrier permeability and brain inflammation in experimental allergic encephalomyelitis.

Authors:  Rajkumar Noubade; Roxana del Rio; Benjamin McElvany; James F Zachary; Jason M Millward; Denisa D Wagner; Halina Offner; Elizabeth P Blankenhorn; Cory Teuscher
Journal:  Am J Pathol       Date:  2008-08-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.